156 related articles for article (PubMed ID: 36874403)
21. Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions.
Zhu A; Gereta S; Zhang TR; Stangl-Kremser J; Mora RM; Margolis DJA; Hu JC
Eur Urol Open Sci; 2023 Jul; 53():38-45. PubMed ID: 37441341
[TBL] [Abstract][Full Text] [Related]
22. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate.
Caramella-Pereira F; Zheng Q; Hicks JL; Roy S; Jones T; Pomper M; Antony L; Meeker AK; Yegnasubramanian S; De Marzo AM; Brennen WN
medRxiv; 2024 Apr; ():. PubMed ID: 38633791
[TBL] [Abstract][Full Text] [Related]
24. Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
Lee MS; Moon MH; Kim YA; Sung CK; Woo H; Jeong H; Son H
AJR Am J Roentgenol; 2018 Jul; 211(1):114-120. PubMed ID: 29702017
[TBL] [Abstract][Full Text] [Related]
25. Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.
Gordetsky JB; Ullman D; Schultz L; Porter KK; Del Carmen Rodriguez Pena M; Calderone CE; Nix JW; Ullman M; Bae S; Rais-Bahrami S
Hum Pathol; 2019 Jan; 83():159-165. PubMed ID: 30179687
[TBL] [Abstract][Full Text] [Related]
26. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.
Drost FH; Osses D; Nieboer D; Bangma CH; Steyerberg EW; Roobol MJ; Schoots IG
Eur Urol; 2020 Jan; 77(1):78-94. PubMed ID: 31326219
[TBL] [Abstract][Full Text] [Related]
27. Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.
Kido A; Tamada T; Kanomata N; Yamamoto A; Miyaji Y; Nagai A; Sone T
Jpn J Radiol; 2019 Feb; 37(2):154-164. PubMed ID: 30600483
[TBL] [Abstract][Full Text] [Related]
28. Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram.
Bjurlin MA; Renson A; Rais-Bahrami S; Truong M; Rosenkrantz AB; Huang R; Taneja SS
Eur Urol Focus; 2019 Sep; 5(5):815-822. PubMed ID: 29802053
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
Harmon SA; Gesztes W; Young D; Mehralivand S; McKinney Y; Sanford T; Sackett J; Cullen J; Rosner IL; Srivastava S; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Dobi A; Sesterhenn IA; Turkbey B
Radiology; 2021 Jun; 299(3):613-623. PubMed ID: 33847515
[TBL] [Abstract][Full Text] [Related]
30. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.
Johnson DC; Raman SS; Mirak SA; Kwan L; Bajgiran AM; Hsu W; Maehara CK; Ahuja P; Faiena I; Pooli A; Salmasi A; Sisk A; Felker ER; Lu DSK; Reiter RE
Eur Urol; 2019 May; 75(5):712-720. PubMed ID: 30509763
[TBL] [Abstract][Full Text] [Related]
31. Risk model based on MRI fusion biopsy characteristics predicts biochemical recurrence after radical prostatectomy.
Chen Z; Wu J; Sun K; He Y; Zhu Z; Xiao L; Sheng L
Prostate; 2022 Apr; 82(5):566-575. PubMed ID: 35067945
[TBL] [Abstract][Full Text] [Related]
32. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
[TBL] [Abstract][Full Text] [Related]
33. Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.
Salami SS; Kaplan JB; Nallandhighal S; Takhar M; Tosoian JJ; Lee M; Yoon J; Hovelson DH; Plouffe KR; Kaffenberger SD; Schaeffer EM; Karnes RJ; Lotan TL; Morgan TM; George AK; Montgomery JS; Davenport MS; You S; Tomlins SA; Curci NE; Kim HL; Spratt DE; Udager AM; Palapattu GS
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914029
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer detection rate according to lesion visibility using ultrasound and MRI.
Choi MH; Lee YJ; Jung SE; Lee JY; Choi YJ
Clin Radiol; 2019 Jun; 74(6):474-479. PubMed ID: 30846191
[TBL] [Abstract][Full Text] [Related]
35. Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
Stavrinides V; Norris JM; Karapanagiotis S; Giganti F; Grey A; Trahearn N; Freeman A; Haider A; Carmona Echeverría LM; Bott SRJ; Brown LC; Burns-Cox N; Dudderidge TJ; El-Shater Bosaily A; Ghei M; Henderson A; Hindley RG; Kaplan RS; Oldroyd R; Parker C; Persad R; Rosario DJ; Shergill IS; Winkler M; Kirkham A; Punwani S; Whitaker HC; Ahmed HU; Emberton M;
Radiology; 2023 Apr; 307(1):e220762. PubMed ID: 36511804
[TBL] [Abstract][Full Text] [Related]
36. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
Mazzone E; Gandaglia G; Ploussard G; Marra G; Valerio M; Campi R; Mari A; Minervini A; Serni S; Moschini M; Marquis A; Beauval JB; van den Bergh R; Rahota RG; Soeterik T; Roumiguiè M; Afferi L; Zhuang J; Guo H; Mattei A; Gontero P; Cucchiara V; Stabile A; Fossati N; Montorsi F; Briganti A
Eur Urol; 2022 Feb; 81(2):193-203. PubMed ID: 34399996
[TBL] [Abstract][Full Text] [Related]
37. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.
Drost FH; Osses DF; Nieboer D; Steyerberg EW; Bangma CH; Roobol MJ; Schoots IG
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012663. PubMed ID: 31022301
[TBL] [Abstract][Full Text] [Related]
38. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P
Eur Urol; 2021 Dec; 80(6):682-689. PubMed ID: 34465492
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.
Grönberg H; Eklund M; Picker W; Aly M; Jäderling F; Adolfsson J; Landquist M; Haug ES; Ström P; Carlsson S; Nordström T
Eur Urol; 2018 Dec; 74(6):722-728. PubMed ID: 30001824
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy.
Chen X; Bernemann C; Tolkach Y; Heller M; Nientiedt C; Falkenstein M; Herpel E; Jenzer M; Grüllich C; Jäger D; Sültmann H; Duensing A; Perner S; Cronauer MV; Stephan C; Debus J; Schrader AJ; Kristiansen G; Hohenfellner M; Duensing S
Urol Oncol; 2018 Apr; 36(4):161.e19-161.e30. PubMed ID: 29198908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
